I have performed virtual screenings for an extracellular AXL tyrosine kinase receptor inhibitor with Raymond Birge PhD's laboratory from the Cancer Center at Rutgers New Jersey Medical School. These compounds we are finding have potential as anticancer, as well as, possibly antiviral therapeutics. The link to their site is:
I have also performed virtual screenings against an ALS target molecule in for Cenoxsys Corp. The link to their site is: